Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Kalkine Stock Watch: Is Telix (ASX:TLX) Worth Considering?

Telix Pharmaceuticals Ltd (ASX:TLX) traded atAUD 13.60on 12 June 2026, recording a modest intraday gain of0.97%. The movement occurred in a trading environment where biotechnology equities were closely monitored for pipeline expansion, partnership announcements, and commercialization visibility across oncology-focused platforms.

Sonal Goyal | 12 June 2026

Kalkine Stock Analysis: Is Cochlear (ASX:COH) a Healthcare Stock Investors Are Watching Closely?

Cochlear Ltd (ASX:COH) finished higher on 12 June 2026, with shares rising 0.84% to close at AU$103.75. Although the gain was relatively modest compared with some of the day's stronger performers, the move highlights continued investor interest in one of Australia's most recognised healthcare …

Aditi Sarkar | 12 June 2026

Kalkine Investor Brief: Vitrafy Life Sciences (ASX:VFY) Advances Commercialisation Strategy With New Funding

Vitrafy Life Sciences Ltd (ASX:VFY) has announced the successful completion of a A$30 million institutional placement, securing support from both existing and new institutional and sophisticated investors. The capital raising follows the company's recent update regarding progress in the US blood market and is …

Aditi Sarkar | 12 June 2026

Kalkine ASX News: Vita Life Sciences (ASX:VLS) Advances as Investors Assess Earnings Guidance

Vita Life Sciences Ltd (ASX:VLS) attracted investor attention on 12 June 2026 after issuing guidance for the half year ending 30 June 2026. During the afternoon trading session, the company's shares climbed 4.32% to AUD 2.54. The positive market reaction followed management's outlook indicating …

Aditi Sarkar | 12 June 2026

Kalkine Stock Analysis: Microba Life Sciences (ASX:MAP): Can New Funding Drive Next Phase of Growth?

Microba Life Sciences Ltd (ASX:MAP) has emerged as one of the more closely watched healthcare technology companies on the Australian Securities Exchange following its latest capital raising announcement. The microbiome diagnostics and therapeutics company attracted investor attention after securing $5 million through a placement …

Sonal Goyal | 12 June 2026

Kalkine Market Watch: Can Microba Life Sciences (ASX:MAP) Recover from Its Recent Decline?

Microba Life Sciences Ltd (ASX:MAP) came under significant selling pressure on 12 June 2026, with shares declining 28.57% to close at AU$0.045. The stock traded close to its 52-week low of AU$0.043 during the session, highlighting the challenges currently facing sentiment toward small-cap biotechnology …

Aditi Sarkar | 12 June 2026

Kalkine Stock Watch: Can Global Expansion Drive TruScreen Group’s (ASX: TRU) Next Phase of Growth?

TruScreen Group Limited (ASX:TRU) remains one of the more closely followed emerging healthcare technology companies on the Australian Securities Exchange as investors assess its expanding global footprint in cervical cancer screening. The company, which develops AI-enabled real-time cervical cancer screening technology, released a significant …

Sonal Goyal | 12 June 2026

Kalkine Stock Analysis: Are Investors Reassessing Alterity Therapeutics' Clinical Pipeline?

Alterity Therapeutics Ltd (ASX: ATH) attracted market attention on 12 June 2026 after its shares climbed 14.61% to AUD 0.51. The stock opened at AUD 0.46 and traded within a range of AUD 0.45 to AUD 0.52 during the session, reflecting increased investor activity …

Aditi Sarkar | 12 June 2026

Kalkine Healthcare Focus: Why Is Tetratherix (ASX:TTX) Among Today's Top Healthcare Gainers?

Tetratherix Ltd (ASX:TTX) attracted investor attention on 12 June 2026 after its shares climbed 13.71% to AUD 5.97. The stock opened at AUD 5.40 and reached an intraday high of AUD 6.00 before trading near those levels during the session.

Aditi Sarkar | 12 June 2026

Kalkine ASX Update: What Is Supporting Momentum in LTR Pharma (ASX:LTP)?

LTR Pharma Ltd (ASX:LTP) attracted investor attention on 12 June 2026 after its shares climbed 16.00% to AUD 0.58. The stock opened at AUD 0.52 and traded within a range of AUD 0.50 to AUD 0.61 during the session, reflecting increased buying activity throughout …

Aditi Sarkar | 12 June 2026
Support

Hi! How can we help you today?

Loading…